Calcimagon is a mineral that is found naturally in foods. Calcimagon is necessary for many normal functions of the body, especially bone formation and maintenance. Calcimagon can also bind to other minerals and aid in their removal from the body. Calcimagon is used to prevent and to treat Calcimagon deficiencies. Calcimagon may also be used for purposes not listed in Calcimagon guide.
Calcimagon side effects
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Call your doctor at once if you have:
little or no urinating;
swelling, rapid weight gain; or
high levels of Calcimagon in the blood--nausea, vomiting, stomach pain, loss of appetite, constipation, increased thirst or urination, muscle pain or weakness, joint pain, confusion, and feeling tired or restless.
Common side effects may include:
nausea or vomiting;
constipation.
decreased appetite;
dry mouth or increased thirst; or
urinating more than usual.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. See also: Side effects
advertisement
Calcimagon dosing
Usual Adult Dose for Osteoporosis:
2500 to 7500 mg/day orally in 2 to 4 divided doses.
Usual Adult Dose for Hypocalcemia:
900 to 2500 mg/day orally in 2 to 4 divided doses. This dose may be adjusted as needed to achieve a normal serum Calcimagon level.
Usual Adult Dose for Dyspepsia:
300 to 8000 mg/day orally in 2 to 4 divided doses. This dose may be increased as needed and tolerated to decrease symptoms of stomach upset. Maximum Dose: 5,500 to 7980 mg. Not to exceed maximum daily dosage for a period of greater than 2 weeks unless directed by a physician.
Usual Adult Dose for Duodenal Ulcer:
1250 to 3750 mg/day in 2 to 4 divided doses. This dose may be increased as needed and tolerated to decrease the abdominal discomfort. The major limiting factor to the chronic use of Calcimagon is gastric hypersecretion and acid rebound.
Usual Adult Dose for Gastric Ulcer:
1250 to 3750 mg/day in 2 to 4 divided doses. This dose may be increased as needed and tolerated to decrease the abdominal discomfort. The major limiting factor to the chronic use of Calcimagon is gastric hypersecretion and acid rebound.
Usual Adult Dose for Erosive Esophagitis:
1250 to 3750 mg/day orally in 2 to 4 divided doses. The potential for acid rebound could be detrimental. However, antacids have been frequently used in the management of erosive esophagitis and may be beneficial in decreasing the acidity of gastric contents. Maximum Dose: 5,500 to 7980 mg. Not to exceed maximum daily dosage for a period of greater than 2 weeks unless directed by a physician.
Usual Adult Dose for Gastroesophageal Reflux Disease:
1250 to 3750 mg/day orally in 2 to 4 divided doses. The potential for acid rebound could be detrimental. However, antacids have been frequently used in the management of erosive esophagitis and may be beneficial in decreasing the acidity of gastric contents. Maximum Dose: 5,500 to 7980 mg (depending on product used). Not to exceed maximum daily dosage for a period of greater than 2 weeks unless directed by a physician.
Usual Pediatric Dose for Hypocalcemia:
Neonatal: Hypocalcemia : Dose expressed in mg of elemental Calcimagon: 50 to 150 mg/kg/day in 4 to 6 divided doses; not to exceed 1 g/day Usual Dosage: Calcimagon: Children 2 to 5 years: Childrens Pepto, Calcimagon (R) Childrens: 1 tablet (400 mg Calcimagon) as symptoms occur; not to exceed 3 tablets/day Children 6 to 11 years: Childrens Pepto, Calcimagon (R) Childrens: 2 tablets (800 mg Calcimagon) as symptoms occur; not to exceed 6 tablets/day Children 11 years and older: Calcimagon (R), Calcimagon (R) E-X: 2 to 4 tablets chewed as symptoms occur; not to exceed 15 tablets [Tums (R)] or 10 tablets [Tums (R) E-X] per day Calcimagon (R) Ultra: 2 to 3 tablets chewed as symptoms occur; not to exceed 7 tablets per day Hypocalcemia (dose depends on clinical condition and serum Calcimagon level): Dose expressed in mg of elemental Calcimagon: Children: 45 to 65 mg/kg/day in 4 divided doses Treatment of hyperphosphatemia in end-stage renal failure: Children and Adults: Dose expressed in mg of Calcimagon: 1 g with each meal; increase as needed; range: 4 to 7 g/day Hydrofluoric acid (HF) burns (HF concentration less than 20%): Topical: Various topical Calcimagon preparations have been used anecdotally for treatment of dermal exposure to HF solutions; Calcimagon at concentrations ranging from 2.5% to 33% has been used; a topical Calcimagon preparation must be compounded.
advertisement
What other drugs can affect Calcimagon?
Other drugs may interact with Calcimagon, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell each of your health care providers about all medicines you use now and any medicine you start or stop using.
Dailymed."Calcium carbonate; famotidine; magnesium hydroxide: dailymed provides trustworthy information about marketed drugs in the united states. dailymed is the official provider of fda label information (package inserts).". https://dailymed.nlm.nih.gov/dailym... (accessed August 28, 2018).
Dailymed."Calcium: dailymed provides trustworthy information about marketed drugs in the united states. dailymed is the official provider of fda label information (package inserts).". https://dailymed.nlm.nih.gov/dailym... (accessed August 28, 2018).
Can Calcimagon be stopped immediately or do I have to stop the consumption gradually to ween off?
In some cases, it always advisable to stop the intake of some medicines gradually because of the rebound effect of the medicine.
It's wise to get in touch with your doctor as a professional advice is needed in this case regarding your health, medications and further recommendation to give you a stable health condition.
Who should not take Calcimagon?
Ask a doctor or pharmacist if it is safe for you to take this medicine if you have other medical conditions, especially:
a history of kidney stones;
a parathyroid gland disorder; or
if you are taking an antibiotic.
Do not use this medicine without a doctor's advice if you are pregnant or breast-feeding. Your dose needs may be different during pregnancy or while you are nursing.
Do not give this medicine to a child without medical advice.
What other drugs will affect Calcimagon?
Follow your healthcare provider's instructions about any restrictions on food, beverages, or activity.
How should I take Calcimagon?
Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended.
Calcimagon works best if you take it with food.
Swallow the Calcimagon tablet or capsule with a full glass of water.
The chewable tablet should be chewed before you swallow it.
Shake the oral suspension well just before you measure a dose. Measure liquid medicine with the dosing syringe provided, or with a special dose-measuring spoon or medicine cup. If you do not have a dose-measuring device, ask your pharmacist for one.
Use the Calcimagon powder as directed. Allow the powder to dissolve completely, then consume the mixture.
Store at room temperature away from moisture and heat.
Can Calcimagon be taken or consumed while pregnant?
Please visit your doctor for a recommendation as such case requires special attention.
Can Calcimagon be taken for nursing mothers or during breastfeeding?
Kindly explain your state and condition to your doctor and seek medical advice from an expert.
advertisement
Reviews
Following the study conducted by gmedication.com on Calcimagon, the result is highlighted below. However, it must be clearly stated that the survey and result is based solely on the perception and impression of visitors and users of the website as well as consumers of Calcimagon. We, therefore, urge readers not to base their medical judgment strictly on the result of this study but on test/diagnosis duly conducted by a certified medical practitioners or physician.
Patient reports
Patient reported useful
No survey data has been collected yet
Patient reported side effects
No survey data has been collected yet
Patient reported price estimates
No survey data has been collected yet
Patient reported frequency of use
No survey data has been collected yet
Patient reported doses
No survey data has been collected yet
Patient reported time for results
No survey data has been collected yet
Patient reported administration
No survey data has been collected yet
Patient reported age
No survey data has been collected yet
Patient reviews
There are no reviews yet. Be the first to write one!